Last reviewed · How we verify

Proparacaine Hydrochloride 0.5% Drop

Retina Vitreous Associates of Florida · Phase 1 active Small molecule

Proparacaine Hydrochloride 0.5% Drop is a topical anesthetic used primarily for ophthalmic procedures. It is not FDA-approved but has been studied in several clinical trials for various indications, including pain reduction during intravitreal injections and probing and irrigation. The drug is a small molecule with a well-established mechanism of action, but its use is limited to off-label applications.

At a glance

Generic nameProparacaine Hydrochloride 0.5% Drop
Also known asLidocaine, Topical, Anesthesia, Anesthetic
SponsorRetina Vitreous Associates of Florida
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: